rhodostomin and Osteoporosis

rhodostomin has been researched along with Osteoporosis* in 1 studies

Other Studies

1 other study(ies) available for rhodostomin and Osteoporosis

ArticleYear
Inhibition of osteoporosis by the αvβ3 integrin antagonist of rhodostomin variants.
    European journal of pharmacology, 2017, Jun-05, Volume: 804

    Integrins are heterodimeric cell surface receptors that mediate cell-cell and cell-matrix interaction. The vitronectin and osteopontin receptor αvβ3 integrin has increased expression levels and is implicated in the adhesion, activation, and migration of osteoclasts on the bone surface as well as osteoclast polarization. αvβ3 integrin plays an important role in osteoclast differentiation and resorption. In addition, Arg-Gly-Asp (RGD)-containing peptides, small molecular inhibitors, and antibodies to αvβ3 integrin have been shown to inhibit bone resorption in vitro and in vivo. Here we examined the effects of a disintegrin HSA-ARLDDL a genetically modified mutant of rhodostomin conjugated with human serum albumin, which is highly selective of αvβ3, on RANKL-induced osteoclastogenesis and ovariectomy (OVX)-induced osteoporosis. In RANKL-induced osteoclastogenesis, HSA-ARLDDL significantly inhibited osteoclast formation, and IC

    Topics: Animals; Disintegrins; Female; Humans; Integrin alphaVbeta3; Male; Mice; Mutation; Oligopeptides; Osteoporosis; Peptides; Protein Domains; Rats; Serum Albumin

2017